My watch list
my.bionity.com  
Login  

91 Current news from israel

rss
matching the following criteria

Evogene and Marrone Bio Innovations Sign Multi-Year Collaborative Agreement

Joint Discovery Efforts to Lead to Novel Insect Control Solutions

28-07-2014

Evogene Ltd. and Marrone Bio Innovations Inc. announced the signing of a multiyear collaborative agreement targeting the joint discovery of novel modes of biological action for insect control, followed by the development and commercialization of new insect control products by each of the ...

more

PolyPid Announces US Patent Allowance for Sustained Release of Nucleic Acid Matrix Compositions

09-07-2014

PolyPid announced that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for U.S. application Serial Number 13/574,040, a patent covering compositions for sustained and/or controlled release of nucleic acid agents. A Notice of Allowance is the formal USPTO ...

more

Increased levels of carbon dioxide could threaten zinc and iron levels in plants

Study by BGU researcher and colleagues on most significant health threat from climate change featured in Nature

02-06-2014

Crops that provide a large share of the global population with most of their dietary zinc and iron will have significantly reduced concentrations of those nutrients at the elevated levels of atmospheric CO2 anticipated by around 2050, according to research published in Nature. Given that an ...

more

'Seeing' bodies with sound (no sight required)

10-03-2014

People born unable to see are readily capable of learning to perceive the shape of the human body through soundscapes that translate images into sound, according to researchers who report their findings in the Cell Press journal Current Biology on March 6. With a little training, soundscapes ...

more

image description
New hope for Gaucher patients

21-01-2014

What causes brain damage and inflammation in severe cases of Gaucher disease? Little is known about the events that lead to brain pathology in some forms of the disease, and there is currently no treatment available – a bleak outlook for sufferers and their families. Now, scientists at the ...

more

Merck Invests in Research Partnerships in Israel to Boost Innovation

02-12-2013

Merck is increasingly counting on partnerships with Israeli biotech companies, as demonstrated by its cooperation with Metabomed and ChanBio, both of which joined the Merck Serono Israel Bioincubator now. Merck is already cooperating with multiple Israeli start-up companies such as Qlight ...

more

Not so dumb

A new kind of genetic switch can target the activities of just one type of brain cell

27-11-2013

Mysterious brain cells called microglia are starting to reveal their secrets thanks to research conducted at the Weizmann Institute of Science. Until recently, most of the glory in brain research went to neurons. For more than a century, these electrically excitable cells were believed to perform ...

more

D-Pharm Commences Phase 2 Study with THR-18 In Stroke Patients Treated with Tissue Plasminogen Activator

18-10-2013

D-Pharm Ltd announced receipt of approval from the regulatory authorities in the Ukraine to commence a Phase IIa clinical study of THR-18, to be given with the clot buster drug tissue plasminogen activator (tPA), in patients with acute ischemic stroke. THR-18 is a synthetic therapeutic peptide ...

more

New allosteric inhibitors of cholesterol synthesis – an alternative to statins?

29-08-2013

Researchers in Israel have identified a new catalytic anti-oxidant that could be a promising alternative to statins – the most prescribed cholesterol-lowering drugs in the world. Statins reduce cholesterol levels in the body by acting as competitive inhibitors of 3-hydroxy-3-methyl-glutaryl-CoA ...

more

Evogene reports first quarter 2013 financial results

14-05-2013

Evogene Ltd. (EVGN) announced its financial results for the first quarter ended March 31, 2013. Revenues for the first quarter of 2013 grew to $4.6 million, compared to $4.2 million for the same period in 2012. Evogene’s current revenues consist primarily of research and licensing revenues ...

more

Page 1 From 10
Subscribe to e-mail updates relating to your search

You will receive via e-mail the latest search results matching your search criteria. This service is free of charge and can be cancelled at any time.

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE